The Novel Small Molecule Inhibitor, OSU-T315, Suppresses Vestibular Schwannoma and Meningioma Growth by Inhibiting PDK2 Function in the AKT Pathway Activation.

Mercado-Pimentel, M E; Igarashi, S; Dunn, A M; Behbahani, M; Miller, C; Read, C M; Jacob, A

Mercado-Pimentel, M E; Igarashi, S; Dunn, A M; Behbahani, M; Miller, C; Read, C M; Jacob, A.

Afiliação

Mercado-Pimentel ME; Ear Institute, University of Arizona, USA; Department of Otolaryngology, University of Arizona, USA; Arizona Cancer Center, University of Arizona, USA.
Igarashi S; Ear Institute, University of Arizona, USA; Department of Otolaryngology, University of Arizona, USA.
Dunn AM; Ear Institute, University of Arizona, USA; Department of Otolaryngology, University of Arizona, USA.
Behbahani M; Ear Institute, University of Arizona, USA; Department of Otolaryngology, University of Arizona, USA.
Miller C; Ear Institute, University of Arizona, USA; Department of Otolaryngology, University of Arizona, USA.
Read CM; Ear Institute, University of Arizona, USA.
Jacob A; Ear Institute, University of Arizona, USA; Department of Otolaryngology, University of Arizona, USA; Arizona Cancer Center, University of Arizona, USA; BIO5 Institute, University of Arizona, USA.

Austin J Med Oncol ; 3(1)2016.

Article em En | MEDLINE | ID: mdl-27642646